Prefer Newsweek on Google to see more of our trusted coverage when you search. A majority of Americans are not planning to get a COVID-19 booster vaccine this season, according to a survey. The Pew ...
A bivalent messenger RNA vaccine targeting both the ancestral and omicron BA.4–BA.5 sublineages of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Pfizer–BioNTech) was introduced in ...
Booster vaccines reduced the risk of COVID‑19–related hospitalization and death, according to a new study of over 3 million adults who had the autumn 2022 vaccine in England. The research led by the ...
Getting a COVID vaccine or booster while pregnant can benefit both the mother and the baby, according to a new study published in the journal Vaccine. Researchers from the Infectious Diseases Clinical ...
On May 20, U.S. Food and Drug Administration (FDA) officials announced that Covid-19 vaccines will no longer be available to everyone. Instead, annual boosters will be limited to people ages 65 and ...
Background On July 30, 2021, the administration of a third (booster) dose of the BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) was approved in Israel for persons who were 60 years of age or older ...
The first new COVID-19 vaccines updated for this fall season should start to be available in mid-September now that both the Food and Drug Administration and the Centers for Disease Control and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results